Ema Yoshioka

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

Hideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi et al. · Scientific Reports · 2018 · 101 citations · Full text

Medicine, Oncology, Radiology +17

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma

Takahiro Sasaki, Manabu Kinoshita, Koji Fujita et al. · Scientific Reports · 2019 · 82 citations · Full text

Medicine, Oncology, Radiology +17

Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network

Ryohei Fukuma, Takufumi Yanagisawa, Manabu Kinoshita et al. · Scientific Reports · 2019 · 75 citations · Full text

Medicine, Oncology, Radiology +17

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts

Toru Umehara, Hideyuki Arita, Ema Yoshioka et al. · Acta Neuropathologica Communications · 2019 · 74 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors

Takahiro Sasaki, Junya Fukai, Yoshinori Kodama et al. · Journal of Neuro-Oncology · 2018 · 59 citations · Full text

Medicine, Geriatric Medicine, Oncology +17